×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| MAKERS LABORATORIES LTD. | NA | NA | NA | NA | 86.9 | 9.83 |
| SUNIL HEALTHCARE LTD | NA | NA | NA | NA | 77.7 | 432.0 |
| VIVO BIO TECH LTD. | NA | NA | NA | NA | 72.5 | 8.56 |
Makers Laboratories Ltd., with Security Code 506919, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 10.6 | 10.8 | 11.5 | 14.9 | 11.2 | 11.5 | 12.3 | 11.5 | 9.5 | 9.7 |
| Expenses | 12.5 | 11.0 | 13.3 | 15.6 | 12.3 | 11.6 | 12.6 | 11.7 | 10.0 | 10.8 |
| Operating Profit | -1.8 | -0.2 | -1.8 | -0.7 | -1.1 | -0.1 | -0.3 | -0.2 | -0.6 | -1.1 |
| OPM % | -17.37% | -1.63% | -15.47% | -4.83% | -9.98% | -1.21% | -2.19% | -1.45% | -5.93% | -11.49% |
| Other Income | 0.1 | 0.2 | 0.2 | 0.7 | 0.1 | 0.1 | 0.1 | 10.2 | 0.6 | 0.0 |
| Interest | 0.4 | 0.3 | 0.3 | 0.4 | 0.4 | 0.5 | 0.4 | 0.3 | 0.1 | 0.1 |
| Depreciation | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 |
| Profit before tax | -2.8 | -0.9 | -2.6 | -1.1 | -2.1 | -1.1 | -1.2 | 9.0 | -0.8 | -1.9 |
| Tax % | -7.5% | -13.8% | -5.9% | -11.1% | -7.2% | 37.1% | -1.4% | -10.6% | -9.2% | 0% |
| Net Profit | -2.6 | -0.8 | -2.5 | -1.0 | -1.9 | -1.6 | -1.2 | 8.0 | -0.8 | -1.4 |
| EPS in Rs | -4.25 | -1.29 | -4.17 | -1.68 | -3.3 | -2.64 | -2.07 | 13.62 | -1.31 | 0 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 19.9 | 29.4 | 25.0 | 25.1 | 26.5 | 27.8 | 29.6 | 29.6 | 27.7 | 33.9 |
| Expenses | 20.1 | 27.7 | 25.1 | 24.9 | 26.3 | 26.9 | 27.8 | 27.4 | 26.4 | 30.7 |
| Operating Profit | -0.2 | 1.8 | -0.1 | 0.2 | 0.2 | 0.9 | 1.8 | 2.2 | 1.3 | 3.2 |
| OPM % | -0.88% | 6.04% | -0.53% | 0.8% | 0.76% | 3.1% | 6.12% | 7.4% | 4.72% | 9.38% |
| Other Income | 0.3 | 0.1 | 0.2 | 0.4 | 0.4 | 0.4 | -0.5 | 10.6 | 0.9 | 0.1 |
| Interest | 0.4 | 0.2 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 0.2 | 0.2 |
| Depreciation | 1.2 | 1.1 | 1.1 | 1.1 | 1.2 | 1.1 | 1.3 | 1.3 | 1.3 | 0.9 |
| Profit before tax | -1.5 | 0.5 | -1.4 | -1.0 | -1.1 | -0.4 | 0.4 | 11.0 | 0.7 | 2.2 |
| Tax % | 17% | -34.1% | 18.5% | 10.9% | -4.9% | 150.8% | 48.8% | -12% | -60.2% | -23.7% |
| Net Profit | -1.8 | 0.3 | -1.7 | -1.1 | -1.1 | -1.0 | -0.7 | 9.8 | 0.3 | 1.6 |
| EPS in Rs | -3.65 | 0.43 | -3.55 | -2.27 | -2.61 | -2.18 | -1.67 | 14.94 | 0.5 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | 1% |
| 3 Years: | 3% |
| TTM: | -8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 172% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 32% |
| 3 Years: | 0% |
| 1 Year: | 17% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 15% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 322% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 32% |
| 3 Years: | 0% |
| 1 Year: | 17% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|